beta-thujaplicin has been researched along with Bile Duct Cancer in 1 studies
beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bai, P | 1 |
| Ge, C | 1 |
| Yang, H | 1 |
| Chen, H | 1 |
| Wan, L | 1 |
| Zhang, Y | 1 |
| Zhang, B | 1 |
| Zeng, Q | 1 |
| Fan, Z | 1 |
| Pei, X | 1 |
| Yue, W | 1 |
| Yan, X | 1 |
1 other study available for beta-thujaplicin and Bile Duct Cancer
| Article | Year |
|---|---|
Screening a redox library identifies the anti-tumor drug Hinokitiol for treating intrahepatic cholangiocarcinoma.
Topics: Animals; Antineoplastic Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cell Line, Tumor; Cel | 2022 |